Insmed Inc. buy Wells Fargo & Company
Start price
08.05.26
/
50%
€89.51
Target price
08.05.27
€136.43
Performance (%)
23.81%
Price
17.08.26
€107.78
Summary
This prediction is currently active. The prediction currently has a performance of 23.81%. This prediction currently runs until 08.05.27. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -7.612% | -7.612% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its price target lowered by Wells Fargo & Company from $177.00 to $160.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat